A Mayo Clinic radiomics model found pancreatic cancer signatures in normal-looking CT scans an average of 475 days before diagnosis,…
Natera's cell-free DNA screening assay earned FDA Breakthrough Device designation after the agency reviewed data across 12 cancer types.
An FDA advisory panel voted on whether to recommend Galleri, the first multi-cancer blood screening test to reach that stage.
ALLocate turns standard microscopes into self-driving leukemia screening tools for low-resource labs.
Throne Science closes a $10M Series A to push its AI toilet sensor toward early cancer detection.
New AI partnerships and imaging research offer health systems integrated cancer detection workflows and a safety net for lung cancer…